Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01575821Not ApplicableCompleted

The Effect of Honey on Nocturnal Cough and Sleep Quality

Role: collaborator

NCT00353184Not ApplicableTerminated

Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years

Role: collaborator

NCT00302783Not ApplicableCompleted

Randomized Controlled Trial of Multi-Source Feedback to Pediatric Residents

Role: collaborator

All 3 trials loaded